about
Positive association of schizophrenia to JARID2 geneAnalysis of protocadherin alpha gene enhancer polymorphism in bipolar disorder and schizophrenia.Catecholamines and aggression: the role of COMT and MAO polymorphisms.Reducing inpatient aggression: does paying attention pay off?Analysis of polymorphisms in AT-rich domains of neuregulin 1 gene in schizophrenia.Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility.Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol.Staff and patient views of the reasons for aggressive incidents: a prospective, incident-based study.Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility.Incidence of the Fuld WAIS-R profile in traumatic brain injury and Parkinson's disease.Differential effect of catechol-O-methyltransferase Val158Met genotype on emotional recognition abilities in healthy men and women.Gender differences in facial emotion recognition in persons with chronic schizophrenia.Public-academic partnerships: integrating state psychiatric hospital treatment and clinical research.Methodological structure for aggression research.Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder.Characteristics of assaultive behavior among psychiatric inpatients.Scopolamine-induced impairment as a potential predictor of Alzheimer's disease in individuals with Apolipoprotein E type 4 alleles.Catechol-O-methyltransferase and Monoamine Oxidase-A Polymorphisms and Treatment Response to Typical and Atypical NeurolepticsAnalysis of protocadherin alpha gene deletion variant in bipolar disorder and schizophreniaSpontaneous segmentation in normal and in time-compressed speech
P50
Q28263150-1FF59D74-7C4B-43A7-9A61-89729602BF6AQ33821683-D0E9C8AF-495B-4D25-9A58-793947EBB252Q36092296-24BAECDE-AA78-41E3-A375-D535D29FD420Q36977699-25BA7D6C-3E5D-4DB2-87C1-AC87B056CD89Q43853288-44499200-8F2A-4DC3-922F-D385A6EE7F75Q44750292-472F459B-5EFE-407A-8BE3-FB9AE0ABD55DQ44943751-D5E4315D-03A9-4CB7-884A-484490E81C86Q45110887-D315F69E-8CD7-4ECA-BDD1-F5FBA7C22634Q46365270-592A7BD8-6172-4736-8F0B-23C5201EB39CQ46520547-A6B7058E-0D4D-4274-8E99-D4F9DA0241D9Q46965378-DD5A1628-4759-48E6-ADFA-15770CF2701BQ48157714-8D6B52A5-0F7A-4056-91E3-338F2D260501Q50899951-F14DA99D-3DF7-4AE2-B569-47649CB50FEAQ50917498-79F42CF8-BEBA-4E7C-A97A-9D4D01D72854Q51886988-CB8F46FD-C16F-457D-8908-4C7842F728FBQ51888449-972D1050-DA1D-4C82-B924-9AB4FB7401B9Q51936252-A5488B70-4107-4771-B536-666A8CEDBA21Q51947841-90C60F29-3DC1-4AB5-A5C6-897C96A72950Q52204282-D3F6C170-ED5D-423C-A2A3-CA0B6B6F91C4Q56791166-C5C82C24-0E6B-459A-970D-B5403261659DQ61894178-D0B89822-B29D-4BD0-B57A-FA864B4AA7FDQ61894307-EEBE39FC-7D95-4338-B3AD-747F0E55AFC6
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Karen Nolan
@ast
Karen Nolan
@en
Karen Nolan
@es
Karen Nolan
@nl
Karen Nolan
@sl
type
label
Karen Nolan
@ast
Karen Nolan
@en
Karen Nolan
@es
Karen Nolan
@nl
Karen Nolan
@sl
prefLabel
Karen Nolan
@ast
Karen Nolan
@en
Karen Nolan
@es
Karen Nolan
@nl
Karen Nolan
@sl
P106
P1153
35497399000
P21
P31
P496
0000-0001-7097-5549